Research Paper Volume 15, Issue 8 pp 3035—3051

TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process

class="figure-viewer-img"

Figure 2. Subgroup analysis of prognosis and construction of prognostic prediction model. (A) Overall survival analysis of TYRO3pos vs. TYRO3neg CRC patients in subgroups demarcated according to each clinicopathological indicators. (B) Nomograms to predict overall survival of CRC patients. Points of each variable were obtained via a vertical line between each variable and the point scale. The predicted survival rate was correlated with the total points by drawing a vertical line from the total points scale to the overall survival.